Annual report pursuant to Section 13 and 15(d)

Consolidated Statement of Stockholders' Equity

v3.22.4
Consolidated Statement of Stockholders' Equity - USD ($)
Total
Series A Redeemable Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
AOCI Attributable to Parent [Member]
Beginning balance, value at Dec. 31, 2020 $ 45,274,925   $ 329 $ 349,367,934 $ (304,093,338)  
Beginning balance, shares at Dec. 31, 2020     3,290,358      
Issuance of common stock, net of issuance costs 59,110,800   $ 85 59,110,715    
Issuance of common stock, net of issuance costs, shares     851,320      
Stock-based compensation expense 9,480,373     9,480,373    
Issuance of common stock upon exercise of stock options $ 944,800   $ 2 944,798    
Issuance of common stock upon exercise of stock options, shares 27,953   27,953      
Change in unrealized gain (loss) on marketable debt securities $ (62,445)         $ (62,445)
Net loss (45,640,426)       (45,640,426)  
Ending balance, value at Dec. 31, 2021 69,108,027   $ 416 418,903,820 (349,733,764) (62,445)
Ending balance, shares at Dec. 31, 2021     4,169,631      
Issuance of common stock, net of issuance costs 1   $ 1 0    
Issuance of common stock, net of issuance costs, shares     1,666      
Stock-based compensation expense 5,719,637     5,719,637    
Issuance of Series A Redeemable Preferred Stock, shares   1,002,247        
Issuance of Series A Redeemable Preferred Stock   $ 100   100    
Redemption of Series A Redeemable Preferred Stock 100 $ 100        
Redemption of Series A Redeemable Preferred Stock, shares   (1,002,247)        
Change in fair value of debt conversion feature 573,002     573,002    
Change in unrealized gain (loss) on marketable debt securities (63,647)         (63,647)
Net loss (42,346,903)       (42,346,903)  
Ending balance, value at Dec. 31, 2022 $ 32,990,017   $ 417 $ 425,196,359 $ 392,080,667 $ 126,092
Ending balance, shares at Dec. 31, 2022     4,171,297